Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor.

Ozer HG, El-Gamal D, Powell B, Hing ZA, Blachly JS, Harrington B, Mitchell S, Grieselhuber NR, Williams K, Lai TH, Alinari L, Baiocchi RA, Brinton L, Baskin E, Cannon M, Beaver L, Goettl VM, Lucas DM, Woyach JA, Sampath D, Lehman AM, Yu L, Zhang J, Ma Y, Zhang Y, Spevak W, Shi S, Severson P, Shellooe R, Carias H, Tsang G, Dong K, Ewing T, Marimuthu A, Tantoy C, Walters J, Sanftner L, Rezaei H, Nespi M, Matusow B, Habets G, Ibrahim P, Zhang C, Mathé EA, Bollag G, Byrd JC, Lapalombella R.

Cancer Discov. 2018 Jan 31. pii: CD-17-0902. doi: 10.1158/2159-8290.CD-17-0902. [Epub ahead of print]

PMID:
29386193
2.

Discovery and characterization of the feline miRNAome.

Laganà A, Dirksen WP, Supsavhad W, Yilmaz AS, Ozer HG, Feller JD, Vala KA, Croce CM, Rosol TJ.

Sci Rep. 2017 Aug 23;7(1):9263. doi: 10.1038/s41598-017-10164-w.

3.

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

Papaioannou D, Shen C, Nicolet D, McNeil B, Bill M, Karunasiri M, Burke MH, Ozer HG, Yilmaz SA, Zitzer N, Behbehani GK, Oakes CC, Steiner DJ, Marcucci G, Powell BL, Kolitz JE, Carter TH, Wang ES, Mrózek K, Croce CM, Caligiuri MA, Bloomfield CD, Garzon R, Dorrance AM.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4641-E4647. doi: 10.1073/pnas.1703142114. Epub 2017 May 22.

4.

Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.

Yilmaz AS, Ozer HG, Gillespie JL, Allain DC, Bernhardt MN, Furlan KC, Castro LT, Peters SB, Nagarajan P, Kang SY, Iwenofu OH, Olencki T, Teknos TN, Toland AE.

Cancer. 2017 Apr 1;123(7):1184-1193. doi: 10.1002/cncr.30459. Epub 2016 Dec 1.

PMID:
27906449
5.

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

Ahn DH, Ozer HG, Hancioglu B, Lesinski GB, Timmers C, Bekaii-Saab T.

Oncotarget. 2016 Feb 2;7(5):5306-12. doi: 10.18632/oncotarget.6632.

6.

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.

Dorrance AM, Neviani P, Ferenchak GJ, Huang X, Nicolet D, Maharry KS, Ozer HG, Hoellarbauer P, Khalife J, Hill EB, Yadav M, Bolon BN, Lee RJ, Lee LJ, Croce CM, Garzon R, Caligiuri MA, Bloomfield CD, Marcucci G.

Leukemia. 2015 Nov;29(11):2143-53. doi: 10.1038/leu.2015.139. Epub 2015 Jun 9.

7.

Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling.

Yeh YY, Ozer HG, Lehman AM, Maddocks K, Yu L, Johnson AJ, Byrd JC.

Blood. 2015 May 21;125(21):3297-305. doi: 10.1182/blood-2014-12-618470. Epub 2015 Apr 1.

8.

Mass spectrometry identification of potential mediators of progestin-only contraceptive-induced abnormal uterine bleeding in human endometrial stromal cells.

Shapiro JP, Basar M, Kayisli UA, Guzeloglu-Kayisli O, Joseph Huang S, Suarez AA, Ozer HG, Schatz F, Lockwood CJ.

Contraception. 2015 Mar;91(3):253-60. doi: 10.1016/j.contraception.2014.11.005. Epub 2014 Nov 21.

9.

Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond.

Mundade R, Ozer HG, Wei H, Prabhu L, Lu T.

Cell Cycle. 2014;13(18):2847-52. doi: 10.4161/15384101.2014.949201. Review.

10.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.

Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, Dave SS, Zhang J, Yilmaz AS, Jaglowski SM, Blum KA, Lozanski A, Lozanski G, James DF, Barrientos JC, Lichter P, Stilgenbauer S, Buggy JJ, Chang BY, Johnson AJ, Byrd JC.

N Engl J Med. 2014 Jun 12;370(24):2286-94. doi: 10.1056/NEJMoa1400029. Epub 2014 May 28.

11.

Identification of medium-sized copy number alterations in whole-genome sequencing.

Ozer HG, Usubalieva A, Dorrance A, Yilmaz AS, Caligiuri M, Marcucci G, Huang K.

Cancer Inform. 2015 Mar 5;13(Suppl 3):105-11. doi: 10.4137/CIN.S14023. eCollection 2014.

12.

Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.

Ozer E, Naiboglu B, Karapinar U, Agrawal A, Ozer HG, Schuller DE.

J Laryngol Otol. 2013 Jul;127(7):676-80. doi: 10.1017/S002221511300128X. Epub 2013 Jun 21.

PMID:
23790108
13.

Intensive care unit versus non-intensive care unit postoperative management of head and neck free flaps: comparative effectiveness and cost comparisons.

Arshad H, Ozer HG, Thatcher A, Old M, Ozer E, Agarwal A, Jafari H, Birkheimer D, Basinger H, Forest LA, Schuller DE, Teknos TN.

Head Neck. 2014 Apr;36(4):536-9. doi: 10.1002/hed.23325. Epub 2013 Jun 18.

14.

DFI: gene feature discovery in RNA-seq experiments from multiple sources.

Ozer HG, Parvin JD, Huang K.

BMC Genomics. 2012;13 Suppl 8:S11. doi: 10.1186/1471-2164-13-S8-S11. Epub 2012 Dec 17.

15.

JNK3 perpetuates metabolic stress induced by Aβ peptides.

Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ, Lim TH, Pastorino L, Kunwar AJ, Walton JC, Nagahara AH, Lu KP, Nelson RJ, Tuszynski MH, Huang K.

Neuron. 2012 Sep 6;75(5):824-37. doi: 10.1016/j.neuron.2012.06.024.

16.

From sequencer to supercomputer: an automatic pipeline for managing and processing next generation sequencing data.

Camerlengo T, Ozer HG, Onti-Srinivasan R, Yan P, Huang T, Parvin J, Huang K.

AMIA Jt Summits Transl Sci Proc. 2012;2012:1-10. Epub 2012 Mar 19.

17.

Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer.

Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LY.

Carcinogenesis. 2012 Sep;33(9):1736-44. doi: 10.1093/carcin/bgs204. Epub 2012 Jun 10.

18.

Neuroendocrine carcinoma of the head and neck: a 20-year case series.

Meacham R, Matrka L, Ozer E, Ozer HG, Wakely P, Shah M.

Ear Nose Throat J. 2012 Mar;91(3):E20-4.

PMID:
22430343
19.

miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.

Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK.

J Neuroimmunol. 2012 Jul 15;248(1-2):32-9. doi: 10.1016/j.jneuroim.2011.10.006. Epub 2011 Nov 9. Review.

20.

Comparing multiple ChIP-sequencing experiments.

Ozer HG, Huang YW, Wu J, Parvin JD, Huang TH, Huang K.

J Bioinform Comput Biol. 2011 Apr;9(2):269-82.

21.

Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.

Orlovsky K, Kalinkovich A, Rozovskaia T, Shezen E, Itkin T, Alder H, Ozer HG, Carramusa L, Avigdor A, Volinia S, Buchberg A, Mazo A, Kollet O, Largman C, Croce CM, Nakamura T, Lapidot T, Canaani E.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7956-61. doi: 10.1073/pnas.1103154108. Epub 2011 Apr 25.

22.

Enabling Data Analysis on High-Throughput Data in Large Data Depository Using Web-Based Analysis Platform - A Case Study on Integrating QUEST with GenePattern in Epigenetics Research.

Camerlengo T, Ozer HG, Yan P, Parvin J, Huang T, Huang K, Perez F, Teng M, Li L, Liu Y, Kurc T.

Proceedings (IEEE Int Conf Bioinformatics Biomed). 2009 Nov 1;1-4(Nov 2009):392-395.

23.

Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia.

Zhang J, Xiang Y, Ding L, Keen-Circle K, Borlawsky TB, Ozer HG, Jin R, Payne P, Huang K.

BMC Bioinformatics. 2010 Oct 28;11 Suppl 9:S5. doi: 10.1186/1471-2105-11-S9-S5.

24.

The impact of surgery in the management of the head and neck carcinoma involving the carotid artery.

Ozer E, Agrawal A, Ozer HG, Schuller DE.

Laryngoscope. 2008 Oct;118(10):1771-4. doi: 10.1097/MLG.0b013e31817f6dc7.

PMID:
18724260
25.

Supplemental Content

Support Center